Skip to content

HOSPINOVA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

HOSPINOVA

BE 0835.268.285
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€197,706
2024 · €108,368+€89,338
Equity
€90,567
2024 · €60,661+€29,906
Cash
€129,390
2024 · €51,156+€78,235
Balance sheet total
€509,654
2024 · €320,176+€189,477

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€100,584

    up €100,584 (+51.2%), from €196,398 to €296,982

    of which Trade receivables: +€114,506

  • Cash +€78,235

    up €78,235 (+153%), from €51,156 to €129,390

    mainly Net result for the year (+€197,706) and Trade debts (+€125,675)

  • Stocks and contracts +€7,731

    up €7,731 (+14.2%), from €54,395 to €62,126

Equity and liabilities
  • Trade debts +€125,675

    up €125,675 (+190%), from €66,082 to €191,757

  • Other debts +€66,190

    up €66,190 (+63.0%), from €105,086 to €171,277

  • Reserves +€30,000

    up €30,000 (+75.0%), from €40,000 to €70,000

  • Debts after one year -€17,305

    down €17,305 (-74.3%), from €23,302 to €5,997

  • Tax, wage and social debts -€15,100

    down €15,100 (-34.5%), from €43,705 to €28,605

    of which Taxes: -€18,707

Income statement
  • Gross operating margin +€114,668

    up €114,668 (+67.3%), from €170,278 to €284,946

  • Taxes +€33,308

    up €33,308 (+93.9%), from €35,458 to €68,766

  • Other operating charges -€20,840

    down €20,840 (-90.2%), from €23,113 to €2,273

  • Financial charges +€13,401

    up €13,401 (+191%), from €7,027 to €20,427

  • Financial income +€2,899

    up €2,899 (+56.0%), from €5,174 to €8,073

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €108,368
Gross operating margin +€114,668
Depreciation -€2,360
Other operating charges +€20,840
Financial income +€2,899
Financial charges -€13,401
Taxes -€33,308
Result 2025 €197,706
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€265,880
Investment -€3,940
Financing -€183,706
Cash 2024 €51,156
Net result for the year +€197,706
Depreciation +€3,846
Stocks and contracts -€7,731
Receivables within one year -€100,584
Deferred charges and accrued income -€2,834
Trade debts +€125,675
Tax, wage and social debts -€15,100
Other debts +€66,190
Accrued charges and deferred income -€1,288
Investment in fixed assets (net) -€3,940
Debts after one year -€17,305
Current portion of long-term debt +€1,400
Contributions, distributions and other -€167,800
Cash 2025 €129,390
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €320,176 €509,654 +€189,477 +59.2%
Fixed assets 21/28 €16,332 €16,426 +€94 +0.6%
Tangible fixed assets 22/27 €16,332 €16,426 +€94 +0.6%
Furniture and vehicles 24 €1,701 €1,014 -€687 -40.4%
Leasing and similar rights 25 - €2,325 +€2,325
Other tangible fixed assets 26 €14,631 €13,088 -€1,544 -10.6%
Current assets 29/58 €303,844 €493,227 +€189,383 +62.3%
Stocks and contracts in progress 3 €54,395 €62,126 +€7,731 +14.2%
Stocks 30/36 €54,395 €62,126 +€7,731 +14.2%
Amounts receivable within one year 40/41 €196,398 €296,982 +€100,584 +51.2%
Trade receivables 40 €163,642 €278,148 +€114,506 +70.0%
Other amounts receivable 41 €32,755 €18,834 -€13,922 -42.5%
Cash at bank and in hand 54/58 €51,156 €129,390 +€78,235 +153%
Deferred charges and accrued income 490/1 €1,895 €4,729 +€2,834 +150%
Total equity and liabilities 10/49 €320,176 €509,654 +€189,477 +59.2%
Equity 10/15 €60,661 €90,567 +€29,906 +49.3%
Contributions 10/11 €20,460 €20,460 = 0.0%
Reserves 13 €40,000 €70,000 +€30,000 +75.0%
Distributable reserves 133 €40,000 €70,000 +€30,000 +75.0%
Profit (loss) carried forward 14 €201 €107 -€94 -46.9%
Amounts payable 17/49 €259,515 €419,087 +€159,572 +61.5%
Amounts payable after more than one year 17 €23,302 €5,997 -€17,305 -74.3%
Financial debts 170/4 €23,302 €5,997 -€17,305 -74.3%
Amounts payable within one year 42/48 €232,901 €411,066 +€178,165 +76.5%
Current portion of amounts payable after more than one year 42 €18,027 €19,427 +€1,400 +7.8%
Trade debts 44 €66,082 €191,757 +€125,675 +190%
Suppliers 440/4 €66,082 €191,757 +€125,675 +190%
Taxes, remuneration and social security 45 €43,705 €28,605 -€15,100 -34.5%
Taxes 450/3 €43,705 €24,998 -€18,707 -42.8%
Remuneration and social security 454/9 - €3,607 +€3,607
Other amounts payable 47/48 €105,086 €171,277 +€66,190 +63.0%
Accrued charges and deferred income 492/3 €3,312 €2,023 -€1,288 -38.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,486 €3,846 +€2,360 +159%
Other operating charges 640/8 €23,113 €2,273 -€20,840 -90.2%
Non-recurring operating charges 66A €0 - =
Gross operating margin 9900 €170,278 €284,946 +€114,668 +67.3%
Operating profit (loss) 9901 €145,678 €278,826 +€133,148 +91.4%
Financial income 75/76B €5,174 €8,073 +€2,899 +56.0%
Recurring financial income 75 €5,174 €8,073 +€2,899 +56.0%
Financial charges 65/66B €7,027 €20,427 +€13,401 +191%
Recurring financial charges 65 €7,027 €20,427 +€13,401 +191%
Profit (loss) for the period before taxes 9903 €143,826 €266,472 +€122,646 +85.3%
Income taxes 67/77 €35,458 €68,766 +€33,308 +93.9%
Profit (loss) for the period 9904 €108,368 €197,706 +€89,338 +82.4%
Profit (loss) for the period to be appropriated 9905 €108,368 €197,706 +€89,338 +82.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.